Currie R W, Ellison J A, White R F, Feuerstein G Z, Wang X, Barone F C
Laboratory of Molecular Neurobiology, Department of Anatomy and Neurobiology, Faculty of Medicine, Dalhousie University, Halifax, Canada.
Brain Res. 2000 Apr 28;863(1-2):169-81. doi: 10.1016/s0006-8993(00)02133-8.
We have established a focal preconditioning (PC) paradigm that produces significant and prolonged ischemic tolerance (IT) of the brain to subsequent permanent middle cerebral artery occlusion (MCAO). PC using 10 min of MCAO induces brain tolerance at 1-7 days of reperfusion that requires active protein synthesis. The protective protein(s) involved are unknown. In these studies the increased transcription and translation of the inducible 70-kDa heat shock protein (Hsp70) and the 27-kDa heat shock protein (Hsp27), and astrogliosis/glial fibrillary acidic protein (GFAP) were determined by Northern analysis and immunohistochemistry following PC. Cellular localization of proteins was determined by double labeling. PC produced no brain injury but did increase Hsp70 mRNA transiently at 6 h and increased Hsp27 mRNA later at 24 h for at least 5 days. Protein expression induced by PC exhibited a similar profile. Hsp70 protein was primarily expressed in neurons from 1 to 5 days post-PC throughout the PC cortex. Hsp27 protein expression was initiated later for a much longer period of time. A remarkable astroglyosis was verified with increased astrocytic Hsp27 from 1 to 7 days after PC. Gliosis with increased Hsp27 in the PC cortex was still present but reduced 4 weeks after PC. Therefore, PC that results in brain tolerance/neuroprotection increases neuronal Hsp70 in the PC cortex and activated astrocytic Hsp27 in the PC cortex in a temporal fashion associated with developing IT. The short duration of benign ischemia (PC) that produces IT produces a robust, long-lived cellular and protein synthetic response that extends throughout the entire cortex (i.e. well beyond the MCA perfusion territory). The resulting IT is associated with changes in astrocyte-activation that might provide increased support and protection from injury. Although both Hsp70 and Hsp27 may participate in the neuroprotection/brain tolerance induced by PC, the temporal expression patterns of these proteins indicate that they are not solely responsible for the tolerance to brain injury.
我们建立了一种局灶性预处理(PC)范式,该范式可使大脑对随后的永久性大脑中动脉闭塞(MCAO)产生显著且持久的缺血耐受(IT)。使用10分钟MCAO进行的PC可在再灌注1 - 7天诱导大脑耐受,这需要活跃的蛋白质合成。所涉及的保护蛋白尚不清楚。在这些研究中,通过Northern分析和免疫组织化学在PC后测定了诱导型70 kDa热休克蛋白(Hsp70)和27 kDa热休克蛋白(Hsp27)的转录和翻译增加,以及星形胶质细胞增生/胶质纤维酸性蛋白(GFAP)。通过双重标记确定蛋白质的细胞定位。PC未造成脑损伤,但在6小时时短暂增加了Hsp70 mRNA,并在24小时后增加了Hsp27 mRNA,至少持续5天。PC诱导的蛋白质表达呈现出类似的模式。在PC后的1至5天内,Hsp70蛋白主要在整个PC皮质的神经元中表达。Hsp27蛋白表达开始较晚,持续时间更长。在PC后1至7天,星形胶质细胞Hsp27增加,证实了明显的星形胶质细胞增生。PC皮质中Hsp27增加的胶质细胞增生在PC后4周仍然存在,但有所减少。因此,导致脑耐受/神经保护的PC以与发展中的IT相关的时间方式增加了PC皮质中的神经元Hsp70和激活的星形胶质细胞Hsp27。产生IT的良性缺血(PC)的短持续时间产生了一种强大、持久的细胞和蛋白质合成反应,该反应延伸至整个皮质(即远远超出MCA灌注区域)。由此产生的IT与星形胶质细胞激活的变化相关,这可能提供增强的支持和免受损伤的保护。尽管Hsp70和Hsp27都可能参与PC诱导的神经保护/脑耐受,但这些蛋白质的时间表达模式表明它们并非单独负责对脑损伤的耐受。